129 related articles for article (PubMed ID: 35076584)
21. Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA.
Raja MAG; Katas H; Amjad MW
Asian J Pharm Sci; 2019 Sep; 14(5):497-510. PubMed ID: 32104477
[TBL] [Abstract][Full Text] [Related]
22. Targeted decationized polyplexes for siRNA delivery.
Novo L; Takeda KM; Petteta T; Dakwar GR; van den Dikkenberg JB; Remaut K; Braeckmans K; van Nostrum CF; Mastrobattista E; Hennink WE
Mol Pharm; 2015 Jan; 12(1):150-61. PubMed ID: 25384057
[TBL] [Abstract][Full Text] [Related]
23. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.
Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D
ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577
[TBL] [Abstract][Full Text] [Related]
24. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
Choi KM; Jang M; Kim JH; Ahn HJ
Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
[TBL] [Abstract][Full Text] [Related]
25. Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol.
Jackson MA; Werfel TA; Curvino EJ; Yu F; Kavanaugh TE; Sarett SM; Dockery MD; Kilchrist KV; Jackson AN; Giorgio TD; Duvall CL
ACS Nano; 2017 Jun; 11(6):5680-5696. PubMed ID: 28548843
[TBL] [Abstract][Full Text] [Related]
26. Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery.
Gosselin MA; Guo W; Lee RJ
Bioconjug Chem; 2002; 13(5):1044-53. PubMed ID: 12236787
[TBL] [Abstract][Full Text] [Related]
27. Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA.
Zhu J; Qiao M; Wang Q; Ye Y; Ba S; Ma J; Hu H; Zhao X; Chen D
Biomaterials; 2018 Apr; 162():47-59. PubMed ID: 29432988
[TBL] [Abstract][Full Text] [Related]
28. Fluorination Enhances Serum Stability of Bioreducible Poly(amido amine) Polyplexes and Enables Efficient Intravenous siRNA Delivery.
Chen G; Wang K; Wang Y; Wu P; Sun M; Oupický D
Adv Healthc Mater; 2018 Mar; 7(5):. PubMed ID: 29280311
[TBL] [Abstract][Full Text] [Related]
29. Additive Polyplexes to Undertake siRNA Therapy against CDC20 and Survivin in Breast Cancer Cells.
Parmar MB; K C RB; Löbenberg R; Uludağ H
Biomacromolecules; 2018 Nov; 19(11):4193-4206. PubMed ID: 30222931
[TBL] [Abstract][Full Text] [Related]
30. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
[TBL] [Abstract][Full Text] [Related]
32. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA.
Katas H; Abdul Ghafoor Raja M; Ee LC
Drug Dev Ind Pharm; 2014 Nov; 40(11):1443-50. PubMed ID: 23962166
[TBL] [Abstract][Full Text] [Related]
33. Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma.
Höbel S; Appeldoorn CC; Gaillard PJ; Aigner A
Pharmaceuticals (Basel); 2011 Dec; 4(12):1591-1606. PubMed ID: 27721338
[TBL] [Abstract][Full Text] [Related]
34. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor targeted methotrexate and small interfering RNA co-delivery.
Steinborn B; Truebenbach I; Morys S; Lächelt U; Wagner E; Zhang W
J Gene Med; 2018 Jul; 20(7-8):e3041. PubMed ID: 29949222
[TBL] [Abstract][Full Text] [Related]
36. siRNA delivery into tumor cells by cationic cholesterol derivative-based nanoparticles and liposomes.
Hattori Y; Hara E; Shingu Y; Minamiguchi D; Nakamura A; Arai S; Ohno H; Kawano K; Fujii N; Yonemochi E
Biol Pharm Bull; 2015; 38(1):30-8. PubMed ID: 25744455
[TBL] [Abstract][Full Text] [Related]
37. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
[TBL] [Abstract][Full Text] [Related]
38. Effect of polymer structure on micelles formed between siRNA and cationic block copolymer comprising thiols and amidines.
Christie RJ; Miyata K; Matsumoto Y; Nomoto T; Menasco D; Lai TC; Pennisi M; Osada K; Fukushima S; Nishiyama N; Yamasaki Y; Kataoka K
Biomacromolecules; 2011 Sep; 12(9):3174-85. PubMed ID: 21863796
[TBL] [Abstract][Full Text] [Related]
39. Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development.
Bégin-Lavallée V; Midavaine É; Dansereau MA; Tétreault P; Longpré JM; Jacobi AM; Rose SD; Behlke MA; Beaudet N; Sarret P
Mol Pain; 2016; 12():. PubMed ID: 27306408
[TBL] [Abstract][Full Text] [Related]
40. Dicer-labile PEG conjugates for siRNA delivery.
Kow SC; McCarroll J; Valade D; Boyer C; Dwarte T; Davis TP; Kavallaris M; Bulmus V
Biomacromolecules; 2011 Dec; 12(12):4301-10. PubMed ID: 22053777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
